Maxacalcitol (trade name Oxarol) is a vitamin D3 analog and vitamin D receptor activator (VDRA).

[1] As a pharmaceutical drug, it is used as an injection to treat secondary hyperparathyroidism resulting from hemodialysis and as a topical ointment for psoriasis.

[2] It was approved for use in Japan in 2010[3] and in Taiwan in 2018.

[4] This dermatologic drug article is a stub.

You can help Wikipedia by expanding it.